Mark Lovell
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$1.4MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $1.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 1, 2018 | NIH | STTR Phase I Commercialization of a Rapid Blood Test for Traumatic Brain Injury | $198K | Fawkes Biotechnology, LLC with UNIVERSITY OF KENTUCKY |
| Sep 30, 2017 | NIH | STTR Phase II Commercialization of a Novel Therapeutic for Alzheimer's Disease | $1.1M | CoPlex Therapeutics, LLC with UNIVERSITY OF KENTUCKY |
| Sep 15, 2016 | NIH | STTR Phase I Target Identification for Novel Small Molecule Therapeutic for Alzheimer's disease | $106K | CoPlex Therapeutics, LLC |
Peer ranks
Federal funding#1,482
Awards as PI#822
Patents#273
Companies
- CoPlex Therapeutics, LLCLinked by awards · Biotech
- Fawkes Biotechnology, LLCLinked by awards · Medtech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.